30 mg
Trade Name
Zyglic MR
modified-release tablet
Request Type
Registration
Drug Type
Generic
Approval Date
SFDA Approved Use
Non‐insulin‐dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.